Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial-Reference-Cited by-同舟云学术

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Published:2016-01 Issue:10013 Volume:387 Page:53-60
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

McCormack Sheena,Dunn David T,Desai Monica,Dolling David I,Gafos Mitzy,Gilson Richard,Sullivan Ann K,Clarke Amanda,Reeves Iain,Schembri Gabriel,Mackie Nicola,Bowman Christine,Lacey Charles J,Apea Vanessa,Brady Michael,Fox Julie,Taylor Stephen,Antonucci Simone,Khoo Saye H,Rooney James,Nardone Anthony,Fisher Martin,McOwan Alan,Phillips Andrew N,Johnson Anne M,Gazzard Brian,Gill Owen N

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Public Health England. HIV in the United Kingdom: 2014 Report. London, 2014.

2. Projected lifetime healthcare costs associated with HIV infection;Nakagawa;PLoS One,2015

3. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic;Phillips;PLoS One,2013

4. HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention;Wilson;PLoS Med,2012

5. WHO ‘Treatment as Prevention’ guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced;Brown;AIDS,2014

Cited by 1501 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a home-based pre-exposure prophylaxis care delivery system for long-acting injectable cabotegravir: a formative exploration of patient preferences;AIDS Care;2024-09-08

2. Lenacapavir to prevent HIV infection: current prices versus estimated costs of production;Journal of Antimicrobial Chemotherapy;2024-09-03

3. Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration;AIDS Care;2024-09-02

4. Determination of intracellular tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots for pre-exposure prophylaxis adherence;Journal of Infection and Chemotherapy;2024-09

5. IAPAC–Lancet HIV Commission on the future of urban HIV responses;The Lancet HIV;2024-09